Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon KohdenTSE:6849 +0.26%68 ROA % is 12.88% as of Mar. 2026, which is 98% above its 10-year median of 6.50. GuruFocus rates TSE:6849 with a GF Score™ of 68/100 and a GF Value™ of 円2,162.06 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Nihon Kohden ranks better than 73.01% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Nihon Kohden's annualizedNet Income for the quarter that ended in Mar. 2026 was 円32,420 Mil.
Nihon Kohden's average Total Assets over the quarter that ended in Mar. 2026 was 円251,650 Mil. Therefore, Nihon Kohden's annualized ROA % for the quarter that ended in Mar. 2026 was 12.88%.
The historical rank and industry rank for Nihon Kohden's ROA % or its related term are showing as below:
TSE:6849'
s ROA % Range Over the Past 10 Years
Min: 5.64 Med: 6.5 Max: 11.62
Current: 5.78
During the past 13 years, Nihon Kohden's highest ROA % was 11.62%. The lowest was 5.64%. And the median was 6.50%.
TSE:6849's ROA % is ranked better than 73.01% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.555
vs TSE:6849: 5.78
Nihon Kohden (TSE:6849) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Nihon Kohden ROA % Related Terms
Nihon Kohden ROA % Historical Data
* Premium members only.
The historical data trend for Nihon Kohden's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nihon Kohden's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Kohden ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's ROA % distribution charts can be found below:
* The bar in red indicates where Nihon Kohden's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Nihon Kohden (TSE:6849) has a ROA % of 12.88% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Nihon Kohden and its competitors. This is 98% above median its historical median of 6.50. Over the past decade, Nihon Kohden's ROA % has ranged from 5.64 to 11.62. According to the industry distribution chart, Nihon Kohden ranks #231 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 27%.
Is Nihon Kohden's ROA % too high?
Nihon Kohden's current ROA % of 12.88% is 98% above median its 10-year median of 6.50. Over the past 10 years, this metric has ranged from a low of 5.64 to a high of 11.62. The Medical Devices & Instruments industry median ROA % is 0.56. Nihon Kohden's value of 12.88% is 2220.7% above this industry median. Based on the distribution chart, Nihon Kohden ranks #231 out of 856 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nihon Kohden has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nihon Kohden's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nihon Kohden ranks #231 out of 856 companies for ROA %. This puts Nihon Kohden in the upper half of its industry. The industry median ROA % is 0.56. Nihon Kohden's value of 12.88% is 2220.7% above this benchmark. Historically, Nihon Kohden's own ROA % has ranged from 5.64 to 11.62 over the past decade. While the company's 10-year median is 6.50 vs. the industry median of 0.56, Nihon Kohden has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Kohden's current ROA % of 12.88% is 2220.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Nihon Kohden and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Kohden's current ROA % is 12.88%, which is 98% above median its own 10-year median of 6.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Kohden stock overvalued right now?
Based on GuruFocus' analysis, Nihon Kohden (TSE:6849) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,162.06, compared to a current price of 円1,542.50 — trading 28.7% below its estimated fair value. The current ROA % is 12.88%, which is 98% above median its 10-year median of 6.50 and 2220.7% above the Medical Devices & Instruments industry median of 0.56. Nihon Kohden's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Nihon Kohden (TSE:6849), the current ROA % is 12.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Kohden (TSE:6849) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Kohden stock appears to be undervalued.
The current stock price of 円1,542.50 is trading 28.7% below its estimated GF Value™ of 円2,162.06.
GuruFocus considers Nihon Kohden to be Modestly Undervalued.
Key valuation signals for TSE:6849:
ROA %: 12.88% (98% above median its 10-year median of 6.50)
GF Value™: 円2,162.06 vs. price of 円1,542.50 (28.7% below fair value)
Industry Position: 2220.7% above the Medical Devices & Instruments median (#231 of 856)
No single metric tells the full story. See the TSE:6849 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
68GF Score
Get the complete analysis for TSE:6849
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6849 has been successfully added to your 
